Latest Period
Q4 2025
Security Snapshot
Twist Bioscience Corp - Common Stock (TWST) Institutional Ownership
CUSIP: 90184D100
13F Institutional Holders and Ownership History from Q4 2018 to Q1 2026
Institutions Reporting
241
Shares (Excl. Options)
75,001,247
Price
$31.72
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock
- Symbol
- TWST on Nasdaq
- Shares outstanding
- 61,275,791
- Price per share
- $50.21
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 75,001,247
- Total reported value
- $2,379,243,293
- % of total 13F portfolios
- 0%
- Share change
- +937,865
- Value change
- +$34,609,150
- Number of holders
- 241
- Price from insider filings
- $50.21
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- TWST - Twist Bioscience Corp - Common Stock is tracked under CUSIP 90184D100.
- 241 institutions reported positions in Q4 2025.
- 8 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 241 to 115 between Q4 2025 and Q1 2026.
- Reported value moved from $2,379,243,293 to $1,046,245,025.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 241 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 90184D100?
CUSIP 90184D100 identifies TWST - Twist Bioscience Corp - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 90184D100:
Significant Owners of Twist Bioscience Corp - Common Stock (TWST) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC | 10% | -17% | $301,406,672 | -$57,820,530 | 6,342,733 | -16% | ARK Investment Management LLC | 31 Mar 2026 |
| Artisan Partners Limited Partnership | 10% | +6.7% | $296,312,372 | +$18,444,801 | 6,217,213 | +6.6% | Artisan Partners Asset Management Inc. | 27 Feb 2026 |
| EdgePoint Investment Group Inc. | 8.8% | +29% | $184,680,211 | +$44,493,376 | 5,377,991 | +32% | EdgePoint Investment Group Inc. | 31 Dec 2025 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 8.6% | -11% | $264,592,541 | -$34,379,339 | 5,269,718 | -11% | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 31 Mar 2026 |
| BlackRock, Inc. | 8.3% | $197,947,718 | 4,927,750 | BlackRock, Inc. | 31 Mar 2025 | |||
| VANGUARD CAPITAL MANAGEMENT LLC | 5% | $147,402,716 | 3,101,909 | Vanguard Capital Management | 31 Mar 2026 | |||
| STATE STREET CORP | 5.1% | +20% | $86,926,233 | +$15,338,157 | 3,089,063 | +21% | STATE STREET CORPORATION | 30 Sep 2025 |
| Invesco Ltd. | 3.9% | $91,850,982 | 2,347,929 | Invesco Ltd. | 30 Jun 2025 |
As of 31 Dec 2025, 241 institutional investors reported holding 75,001,247 shares of Twist Bioscience Corp - Common Stock (TWST). This represents 122% of the company’s total 61,275,791 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Twist Bioscience Corp - Common Stock (TWST) together control 101% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 12% | 7,559,495 | +12% | 1.6% | $239,787,194 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 9.7% | 5,954,429 | +44% | 0.53% | $188,874,488 |
| BlackRock, Inc. | 9.6% | 5,894,972 | -4.6% | 0% | $186,988,511 |
| Artisan Partners Limited Partnership | 9.5% | 5,830,205 | -9.1% | 0.28% | $184,934,095 |
| VANGUARD GROUP INC | 9.4% | 5,776,198 | +0.14% | 0% | $183,221,001 |
| EdgePoint Investment Group Inc. | 8.8% | 5,377,991 | +32% | 1.4% | $170,589,875 |
| STATE STREET CORP | 5.9% | 3,627,818 | +17% | 0% | $115,074,387 |
| Amova Asset Management Americas, Inc. | 3.1% | 1,902,829 | -10% | 0.7% | $60,262,594 |
| Sumitomo Mitsui Trust Group, Inc. | 3.1% | 1,902,829 | -10% | 0.04% | $60,357,736 |
| Soleus Capital Management, L.P. | 3% | 1,861,802 | -0.24% | 2.5% | $59,056,359 |
| GOLDMAN SACHS GROUP INC | 2.8% | 1,696,594 | +4.3% | 0.01% | $53,815,962 |
| MILLENNIUM MANAGEMENT LLC | 2.4% | 1,497,746 | -17% | 0.03% | $47,508,503 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 1,459,274 | +0.75% | 0% | $46,296,523 |
| Thrivent Financial for Lutherans | 2.2% | 1,361,355 | -7% | 0.08% | $43,182,000 |
| Invesco Ltd. | 2.1% | 1,290,271 | -28% | 0.01% | $40,927,396 |
| BAILLIE GIFFORD & CO | 2.1% | 1,276,195 | +1.1% | 0.03% | $40,480,906 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.9% | 1,173,100 | +4.4% | 0.01% | $37,210,731 |
| First Light Asset Management, LLC | 1.9% | 1,140,771 | -4.5% | 2.8% | $36,185,256 |
| MORGAN STANLEY | 1.4% | 866,356 | -42% | 0% | $27,480,827 |
| AMERICAN CENTURY COMPANIES INC | 1.4% | 865,634 | +3.3% | 0.01% | $27,457,993 |
| Tao Capital Management LP | 1.4% | 828,815 | 0% | 23% | $26,290,012 |
| DIMENSIONAL FUND ADVISORS LP | 1.3% | 815,369 | +3.1% | 0.01% | $25,864,898 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.3% | 813,122 | +171% | 0% | $25,792,229 |
| UBS Group AG | 1.1% | 662,317 | +29% | 0% | $21,008,695 |
| JENNISON ASSOCIATES LLC | 1% | 618,933 | -2.5% | 0.01% | $19,632,554 |
Institutional Holders of Twist Bioscience Corp - Common Stock (TWST) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 22,013,669 | $1,046,245,025 | -$67,060,160 | $47.52 | 115 |
| 2025 Q4 | 75,001,247 | $2,379,243,293 | +$34,609,150 | $31.72 | 241 |
| 2025 Q3 | 73,764,582 | $2,075,556,896 | +$57,804,960 | $28.14 | 235 |
| 2025 Q2 | 71,133,390 | $2,616,814,853 | +$58,445,660 | $36.79 | 240 |
| 2025 Q1 | 69,532,083 | $2,729,868,536 | +$98,718,253 | $39.26 | 260 |
| 2024 Q4 | 66,360,913 | $3,083,489,168 | +$6,148,856 | $46.47 | 244 |
| 2024 Q3 | 66,073,350 | $2,986,931,967 | -$9,670,153 | $45.18 | 240 |
| 2024 Q2 | 65,972,475 | $3,251,056,592 | +$28,344,193 | $49.28 | 256 |
| 2024 Q1 | 67,075,830 | $2,301,195,873 | +$12,173,886 | $34.31 | 230 |
| 2023 Q4 | 66,744,591 | $2,459,763,309 | +$20,095,641 | $36.86 | 215 |
| 2023 Q3 | 66,341,769 | $1,344,049,066 | -$31,879,539 | $20.26 | 191 |
| 2023 Q2 | 68,103,043 | $1,393,371,812 | +$106,475,508 | $20.46 | 185 |
| 2023 Q1 | 63,810,827 | $961,273,962 | +$17,347,246 | $15.08 | 197 |
| 2022 Q4 | 62,336,899 | $1,484,114,188 | +$31,639,333 | $23.81 | 191 |
| 2022 Q3 | 59,850,512 | $2,097,211,101 | +$44,899,500 | $35.24 | 206 |
| 2022 Q2 | 57,994,411 | $2,008,438,723 | -$90,076,201 | $34.96 | 188 |
| 2022 Q1 | 54,121,106 | $2,662,382,357 | +$281,218,717 | $49.38 | 193 |
| 2021 Q4 | 51,230,952 | $3,958,124,330 | +$152,934,374 | $77.39 | 224 |
| 2021 Q3 | 48,658,857 | $5,195,018,312 | +$41,898,607 | $106.97 | 229 |
| 2021 Q2 | 48,123,755 | $6,401,051,212 | +$152,118,907 | $133.25 | 240 |
| 2021 Q1 | 46,988,226 | $5,820,040,994 | +$482,887,437 | $123.86 | 234 |
| 2020 Q4 | 42,909,917 | $6,062,828,297 | +$547,775,260 | $141.29 | 215 |
| 2020 Q3 | 39,702,868 | $3,018,023,941 | +$217,077,489 | $75.97 | 191 |
| 2020 Q2 | 37,011,859 | $1,675,114,837 | +$285,296,567 | $45.30 | 141 |
| 2020 Q1 | 30,828,177 | $943,220,817 | +$343,349,207 | $30.58 | 116 |
| 2019 Q4 | 19,740,464 | $414,547,368 | +$39,243,468 | $21.00 | 92 |
| 2019 Q3 | 15,673,899 | $374,288,352 | +$37,099,334 | $23.88 | 82 |
| 2019 Q2 | 13,908,043 | $401,736,443 | +$231,712,763 | $29.01 | 83 |
| 2019 Q1 | 6,003,624 | $137,709,000 | -$1,684,002 | $23.18 | 47 |
| 2018 Q4 | 6,077,977 | $137,438,000 | +$137,438,002 | $23.09 | 46 |